Retour
Fourchette du Jour
70,97 €
73,64 €
Fourchette 52 Semaines
55,17 €
170,87 €
Volume
480 220
Moyenne 50J / 200J
91,52 €
/
111,11 €
Clôture Précédente
69,84 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (626 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -100,5 | 0,4 |
| P/B | 6,9 | 2,9 |
| ROE % | -7,6 | 3,8 |
| Net Margin % | -4,9 | 3,9 |
| Rev Growth 5Y % | 19,1 | 10,0 |
| D/E | 0,5 | 0,2 |
Points Clés
Revenue grew 19,14% annually over 5 years — strong growth
Debt/Equity of 0,49 — conservative balance sheet
Generating 14,26M in free cash flow
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 20,83%
Capital efficient — spends only 4,45% of revenue on capex
Croissance
Revenue Growth (5Y)
19,14%
Revenue (1Y)39,97%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
-7,60%
ROIC-1,92%
Net Margin-4,92%
Op. Margin-2,76%
Sécurité
Debt / Equity
0,49
Current Ratio2,46
Interest Coverage-4,65
Valorisation
P/E Ratio
-100,51
P/B Ratio6,86
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 39,97% | Revenue Growth (3Y) | 45,28% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 19,14% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 427,54M | Net Income (TTM) | -21,02M |
| ROE | -7,60% | ROA | -3,69% |
| Gross Margin | 69,74% | Operating Margin | -2,76% |
| Net Margin | -4,92% | Free Cash Flow (TTM) | 14,26M |
| ROIC | -1,92% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,49 | Current Ratio | 2,46 |
| Interest Coverage | -4,65 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -100,51 | P/B Ratio | 6,86 |
| P/S Ratio | 4,94 | PEG Ratio | 2,67 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 2,11B | Enterprise Value | 2,16B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 427,54M | 305,45M | 202,57M | 234,69M | 212,20M |
| Net Income | -21,02M | -52,29M | -175,77M | -548,98M | -245,39M |
| EPS (Diluted) | -0,73 | -1,94 | -7,23 | -53,63 | -74,93 |
| Gross Profit | 298,17M | 194,40M | 90,01M | -26,75M | -16,60M |
| Operating Income | -11,80M | -23,21M | -180,60M | -667,65M | -446,15M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 570,19M | 419,38M | 418,76M | 545,26M | 554,09M |
| Total Liabilities | 262,01M | 174,13M | 190,74M | 291,56M | 165,99M |
| Shareholders' Equity | 308,18M | 245,25M | 228,02M | 253,71M | 388,10M |
| Total Debt | 151,95M | 116,17M | 119,77M | 77,13M | 32,85M |
| Cash & Equivalents | 105,00M | 85,21M | 99,68M | 137,40M | 400,57M |
| Current Assets | 268,29M | 197,97M | 182,34M | 212,62M | 483,54M |
| Current Liabilities | 108,91M | 54,82M | 58,82M | 144,30M | 101,28M |